ライフサイエンスコーパス: RR

1 RR selection influences reliable early measurement of Ab

2 RR-BLUP, Bayesian A, B, Cpi, LASSO, Ridge Regression and

3 86) and sedentary lifestyle (43.4% to 29.0%; RR = 0.69) declined.

4 redicted violent behavior (RR=13.9, p=0.001; RR=8.3, p=0.003, respectively) during follow-up, as well

5 ves defined by maximum temperature at lag 1 (RR = 1.02; 95% CI: 1.00, 1.04).

6 int (3.3% [69 of 2100] vs 1.9% [23 of 1193]; RR 1.64 [95% CI 1.03-2.61], p=0.0376) and device thrombo

7 o graduated from medical school before 1940 (RR, 3.86; 95% CI: 1.21, 12.3).

8 igher risks for prematurity (11.8% vs 17.2%; RR, 1.48; 95% CI, 1.00-2.19), NICU admission (12.1% vs 1

9 derweight pregnant women (BMI <18.5 kg/m(2); RR 0.84, 95% CI 0.78-0.91; p=0.01).

10 ith SGA and only in women with values >-0.5 (RR: 0.579; 95% CI: 0.463, 0.724).Protection against deli

11 The prevalence of smoking (42.6% to 36.5%; RR = 0.86) and sedentary lifestyle (43.4% to 29.0%; RR =

12 f-pocket for healthcare from 34.4% to 58.7% (RR = 1.69) between 2010 and 2015.

13 , 1.05-2.25), and SGA status (9.2% vs 12.7%; RR, 1.51; 95% CI, 0.94-2.42).

14 1.00-2.19), NICU admission (12.1% vs 17.7%; RR, 1.54; 95% CI, 1.05-2.25), and SGA status (9.2% vs 12

15 the black/pardo group compared with a 6.8% (RR: 0.932; 95% CI: 0.892-0.974) reduction in the white g

16 rding to the Patient Health Questionnaire-9 [RR, 2.3; 95% CI, 1.5 to 3.5]).

17 significantly increased from 10.0% to 21.9% (RR = 2.10) and the proportion of people paying out-of-po

18 se who spent more time in screen activities (RR = 0.98) and sleeping (RR = 0.96) had the lowest compl

19 24 885] versus 4.3% [168 of 3957]; adjusted RR, 1.20; 95% CI, 1.02-1.41; P=0.02), but this survival

20 esent at 3 years (3.5% versus 2.9%; adjusted RR, 1.17; 95% CI, 0.95-1.45; P=0.15) and at 5 years (2.3

21 ) and at 5 years (2.3% versus 1.9%; adjusted RR, 1.18; 95% CI, 0.88-1.58; P=0.27).

22 dark tan vs. no tan, multivariable-adjusted RR = 0.98, 95% CI: 0.92, 1.05), skin reaction to prolong

23 r type IV vs. type I, multivariable-adjusted RR = 0.99, 95% CI: 0.92, 1.05).

24 ctically no reaction, multivariable-adjusted RR = 1.01, 95% CI: 0.93, 1.08), or Fitzpatrick skin phot

25 ose tumors did have KRAS mutations (adjusted RR, 0.59; 95% CI 0.35-1.03; P = .062; P = .90 for the in

26 ors did not contain KRAS mutations (adjusted RR, 0.81; 95% CI, 0.56-1.18; P = .273) or whose tumors d

27 The adjusted RR of HO-CDI for hospitals that both experienced a short

28 f offspring obesity at ages 6-11 y (adjusted RR: 2.39; 95% CI: 1.97, 2.89) and 12-19 y (adjusted RR:

29 9; 95% CI: 1.97, 2.89) and 12-19 y (adjusted RR: 2.74; 95% CI: 2.13, 3.52).

30 f overweight or obesity at age 7 y [adjusted RR (aRR) comparing the highest with the lowest quartile:

31 54, 0.85) but increased by 23% 2 days after (RR = 1.23, 95% CI: 1.01, 1.49); cold-related admissions

32 egimen), and increasing the efficacy against RR TB from 76% to 94% lowered RR TB mortality by 13% (95

33 omes) and multi-compartment compliance aids (RR=2.3, 95%CI 1.1 to 4.9, p=0.03), and between original

34 n did iron-folic acid supplementation alone (RR 0.85, 95% CI 0.75-0.96 vs 1.06, 0.95-1.17; p value fo

35 E in the insulin glargine U100 group, for an RR of 0.64 (95% CI, 0.56-0.73; P < .001 for noninferiori

36 function (RD, 0.03; 95% CI, 0.01 to 0.06 and RR, 3.67; 95% CI, 1.15 to 11.69), with highest risk in c

37 function (RD, 0.05; 95% CI, 0.01 to 0.10 and RR, 2.32; 95% CI, 1.17 to 4.59) and visual motor functio

38 ce by an estimated 32% (95% UR: 18%-46%) and RR TB mortality by 30% (95% UR: 18%-44%).

39 R, 2.66; 95% CI, 1.45-4.88 for >210 days and RR, 2.56; 95% CI, 1.29-5.08 for 151-210 days compared wi

40 t the time of novel regimen introduction and RR TB incidence and mortality of 6 (95% UR: 4-10) and 0.

41 RR, 2.44; 95% CI, 1.35-4.43 for >4500 mg and RR, 2.17; 95% CI, 1.07-4.40 for 3001-4500 mg compared wi

42 he TTTV PAM, the RVR (S542R/K548V/N552R) and RR (S542R/K607R) variants can efficiently recognize the

43 resolution crystal structures of the RVR and RR variants bound to a crRNA and its target DNA.

44 The structures revealed that the RVR and RR variants primarily recognize the PAM-complementary nu

45 corresponding regimens by 50% reduced TB and RR TB mortality by 2% (95% UR: 1%-4%) and 6% (95% UR: 3%

46 on alteplase plus parenteral anticoagulants (RR 1.47 [95% CI 1.10-1.98] for tenecteplase plus parente

47 treptokinase plus parenteral anticoagulants; RR 1.26 [1.10-1.45] for non-accelerated alteplase plus p

48 SUVs for any RR were not significantly different over time.

49 proteins possess a conserved twin-arginine (RR) motif in their signal peptides that is involved in t

50 arm compared with 1.5% in the ALMANACH arm (RR 0.42, 95% CI 0.20, 0.87, p = 0.02).

51 HIV than those in the standard of care arm (RR 1.51, 95% CI 1.29-1.77, p < 0.001) and those in the f

52 1) and those in the facility collection arm (RR 1.22, 95% CI 1.08-1.37, p = 0.001).

53 the delivery arm compared to the coupon arm (RR = 1.14, 95% CI 1.05-1.23, P = 0.001) at 1 month, but

54 , and severe illness (n = 23) was defined as RR >/= 65 and SaO2 </= 92%.

55 tion in the acquisition of MDR A. baumannii (RR, 0.28 [95% CI, .18-.43] and 0.48 [95% CI, .35-.66], r

56 ne significantly predicted violent behavior (RR=13.9, p=0.001; RR=8.3, p=0.003, respectively) during

57 rovided greater reductions in preterm birth (RR 0.89, 95% CI 0.85-0.93; p=0.03).

58 ame tooth (RR: 2.77), and percentage of BOP (RR: 1.49).

59 nce interval [CI], 1.34-5.21) and bupropion (RR: 1.42; 95% CI, 1.01-2.01) were associated with greate

60 as calculated by dividing cortex activity by RR activity, with a composite SUVR averaged over 6 corti

61 (RR = 1.42; 95% CI: 1.24, 1.63), and cancer (RR = 1.62; 95% CI: 1.22, 2.17) compared with those worki

62 f clinical failure compared to routine care (RR 0.51, 95% CI 0.31, 0.84, p = 0.007) and lowered antib

63 0%) and of waitlist dropout from all causes (RR, 0.38; 95% CI, 0.060-2.370; I(2) = 85.7%) compared to

64 dren (RR = 0.81), earlier maturing children (RR = 0.93), and those who spent more time in screen acti

65 omplied more, but overweight/obese children (RR = 0.81), earlier maturing children (RR = 0.93), and t

66 ticularly high among low-income communities (RR 1.076; 95% CI, 1.052, 1.100).

67 nd perhaps with serious liver complications (RR, 1.15; 95% CI, 0.98 to 1.33).

68 olled patients with histologically confirmed RR-DTC stratified by age (</= 65 or > 65 years).

69 umbers of patients with laboratory-confirmed RR-TB and those reported to have started second-line tre

70 5% CI: 1.15-1.88) and individual counseling (RR: 1.64, 95% CI: 1.17-2.28) were both more efficacious

71 atients who received vancomycin alone (crude RR 0.58, 95% CI 0.18, 1.88).

72 P (RR, 3.19; 95% CI, 2.62-3.90) and hs-cTnT (RR, 4.86; 95% CI, 3.03-7.08) were associated with CMIs.

73 psis compared with silver-impregnated cuffs (RR, 0.54 [95% CI, .29-.99]).

74 in the 6 days after a moderate snowfall day (RR = 1.18, 95% CI: 1.09, 1.27).

75 ons increased by 3.7% on high snowfall days (RR = 3.7, 95% CI: 1.6, 8.6) and remained high for 5 days

76 red greater length of stay (7 versus 6 days; RR 1.15; 95% CI 1.1-1.19; P < 0.001).

77 (n=101; 41.6 cases per 10 000 exposure days; RR 0.85, 95% CI 0.69-1.04; p=0.116), or bleach and UV (n

78 (n=131; 45.6 cases per 10 000 exposure days; RR 0.91, 95% CI 0.76-1.09; p=0.303) among exposed patien

79 and had a higher risk of in-hospital death (RR, 1.18; 95% CI, 1.03-1.33) but had no significant incr

80 round-based monitors for circulatory deaths [RR = 1.02, 95% confidence interval (CI): 1.00, 1.04 per

81 men classified as having low breast density (RR, 1.53; 95% CI: 1.13, 2.10) or high breast density (RR

82 95% CI: 1.13, 2.10) or high breast density (RR, 2.86; 95% CI: 1.42, 6.25).

83 d treatment delay among laboratory-diagnosed RR-TB patients.

84 ing approximately 300 sequentially diagnosed RR-TB patients per South African province, were drawn fr

85 l (CI): 1.06, 1.53), cardiovascular disease (RR = 1.42; 95% CI: 1.24, 1.63), and cancer (RR = 1.62; 9

86 ained associated with biliary tract disease (RR, 1.19; 95% CI, 1.08 to 1.31) and perhaps with serious

87 ith 1-90 days) and with the cumulative dose (RR, 2.44; 95% CI, 1.35-4.43 for >4500 mg and RR, 2.17; 9

88 r clinical AL progression than non-drinkers (RR = 0.52; 95% CI: 0.30 to 0.89), whereas those drinking

89 The SUV ratio (SUVR) for each RR was calculated by dividing cortex activity by RR acti

90 as associated with increased risk of eczema (RR=2.02, 95% CI: 1.10-3.72).

91 sitive airway pressure had similar efficacy (RR, 1.11; 95% CI, 0.84-1.47).

92 p = 0.002), assessment for ART eligibility (RR 1.20, 95% CI 1.07-1.34, p = 0.004), ART initiation (R

93 - 2.2 sec, respectively, while the estimated RR and TV values were 0 breaths/min and less than 100 ml

94 .14-1.75), Asian/Pacific Islander ethnicity (RR to white, 1.7; 95% CI, 1.22-2.43), detection of 2 ade

95 ntly more treatment-emergent adverse events (RR, 1.07; 95% CI, 1.01-1.12; P = .01 or RR, 1.49; 95% CI

96 he reporting method), severe adverse events (RR, 1.76; 95% CI, 1.34-2.32; P < .001), and study discon

97 study discontinuation due to adverse events (RR, 1.79; 95% CI, 1.38-2.32; P < .001).

98 in the incidence of serious adverse events (RR: 1.02; 95% CI: 0.94 to 1.09) or renal failure (RR: 1.

99 tion of 2 adenomas at the index examination (RR vs 1 adenoma, 1.47; 95% CI, 1.27-1.71), more than 3 s

100 3 serrated polyps at the index examination (RR=2.16, 95% CI, 1.59-2.93), or index examination with f

101 Doxapram did not aid successful extubation (RR, 0.80; 95% CI, 0.22-2.97).

102 with a 58% increased risk of heart failure (RR 1.58; 95% CI, 1.46 to 1.72) and a 40% increased risk

103 CI: 0.45 to 0.98), and 37% in heart failure (RR: 0.63; 95% CI: 0.43 to 0.99) compared with standard B

104 .02; 95% CI: 0.94 to 1.09) or renal failure (RR: 1.81; 95% CI: 0.86 to 3.80) between the 2 groups.

105 DBT plus synthetic 2D imaging than for FFDM (RR, 1.93; 95% CI: 1.31, 2.03).

106 called patients who were screened with FFDM (RR, 1.81; 95% CI: 1.34, 2.47).

107 ts (RR: 0.76; 95% CI: 0.69, 0.84), and fish (RR: 0.93; 95% CI: 0.88, 0.98), the risk of all-cause mor

108 RR, 0.14 [95% CI, .05-.36]), 5-fluorouracil (RR, 0.34 [95% CI, .14-.82]), and chlorhexidine-silver su

109 bles (RR: 0.96; 95% CI: 0.95, 0.98), fruits (RR: 0.94; 95% CI: 0.92, 0.97), nuts (RR: 0.76; 95% CI: 0

110 standard repair vs 36/368 [10%] with graft, RR 1.57, 0.95 to 2.59; p=0.08).

111 ke (for each daily serving) of whole grains (RR: 0.92; 95% CI: 0.89, 0.95), vegetables (RR: 0.96; 95%

112 s after surgery compared with the AMT group (RR, 0.53, 95% confidence interval [CI], 0.33-0.85).

113 4 (7%) of 359 patients in the control group (RR 0.40, 0.19-0.82; p=0.01).

114 tion group versus 0.7% in the control group (RR 1.72, 95% CI 0.71 to 4.16, P = 0.231).

115 1,952 (25.4%) children in the control group (RR = 0.90 [95% confidence intervals 0.80-1.00]).

116 lower than the 99.4% in the surgical group, (RR 0.75; 95% CI 0.7-0.79; P = 0.00001; I = 62%).

117 in group vs 48 [4.3%] for the control group; RR, 0.93; 95% CI, 0.63-1.39; P = .74) or noncardiac deat

118 in group vs 11 [1.0%] for the control group; RR, 1.39; 95% CI, 0.64-3.01; P = .40).

119 The recall rate was similar between groups (RR, 0.95; 95% CI: 0.84, 1.06), whereas the recall rate w

120 inal vein occlusion (RR 12.9), macular hole (RR 7.7), and epiretinal membrane (RR 5.7).

121 idual N291G and P294K substitutions in human RR additively affect substrate specificity.

122 p were more likely to be admitted to an ICU (RR, 1.68; 95% CI, 1.54-1.82) and had a higher risk of in

123 IBP accumulated in RR and was partly translocated to SL.

124 We included RR-tuberculosis patients detected using Xpert at the Sou

125 tine replacement therapies was inconclusive (RR: 1.22; 95% CI, 0.72-2.06).

126 , 1.33; 95% CI, 1.17-1.52), body mass index (RR, 1.40; 95% CI, 1.22-1.61), and high intake of fat or

127 creased risk of acute myocardial infarction (RR 1.40; 95% CI, 1.23 to 1.59).

128 ; 95% CI, 0.59-1.18), myocardial infarction (RR, 0.47; 95% CI, 0.20-1.11), and stroke (RR, 1.26; 95%

129 , surveillance tests positive for influenza (RR, 1.02; 95% CI, 1.01-1.02), but not RSV (RR, 0.99; 95%

130 ion model that included traffic information (RR = 1.14, 95% CI: 1.11, 1.17 per 10 mug/m(3) increment

131 was increased by 25% with strong inhibitors (RR, 1.25; 95% CI, 1.01-1.54) and highest during the firs

132 anticoagulants plus glycoprotein inhibitors; RR 1.88 [1.24-2.86] for reteplase plus parenteral antico

133 5% CI 1.07-1.34, p = 0.004), ART initiation (RR 1.16, 95% CI 0.96-1.40, p = 0.12), mean time to ART i

134 6.0), self-destructiveness (eg, self-injury [RR, 1.7; 95% CI, 1.2 to 2.4]), and psychological problem

135 CI], 1.12-1.15) and nonoutlier institutions (RR, 1.13; 95% CI, 1.11-1.14) increased in a similar fash

136 th Medicaid compared with private insurance (RR, 1.36; 95% CI, 1.09-1.70).

137 R, 2.47; 95% CI, 2.12-2.87), alcohol intake (RR, 1.33; 95% CI, 1.17-1.52), body mass index (RR, 1.40;

138 rsus reinitiating the same statin intensity (RR, 1.10; 95% CI, 1.05-1.16) and reinitiating a differen

139 Patients with prior laboratory RR-TB diagnoses within 6 mo and currently treated patien

140 at 12 months regardless of time to linkage (RR 1.48, 95% CI 1.18-1.86, p = 0.002), assessment for AR

141 ficacy against RR TB from 76% to 94% lowered RR TB mortality by 13% (95% UR: 6%-23%).

142 was associated with a 29% reduction in MACE (RR: 0.71; 95% CI: 0.60 to 0.84), 33% in cardiovascular m

143 .10; 95% CI: 1.04, 1.18) and processed meat (RR: 1.23; 95% CI: 1.12, 1.36) was associated with an inc

144 tality decreased; higher intake of red meat (RR: 1.10; 95% CI: 1.04, 1.18) and processed meat (RR: 1.

145 ular hole (RR 7.7), and epiretinal membrane (RR 5.7).

146 ue formation in virally suppressed HIV+ men (RR 1.52, 95% CI 1.04-2.22); Gal-3BP and Gal-3 were not a

147 he facility collection arm, both at 1 month (RR 1.18, 95% CI 1.07-1.31, p = 0.001) and at 4 months (R

148 o care regardless of retention at 12 months (RR 1.08, 95% CI 0.97-1.21, p = 0.13), mean time to linka

149 5% CI 1.07-1.31, p = 0.001) and at 4 months (RR 1.03, 95% CI 1.01-1.05, p = 0.02).

150 5% CI 1.17-1.51, p < 0.001) and at 4 months (RR 1.14, 95% CI 1.07-1.22, p < 0.001).

151 pression among those on ART for >/=6 months (RR 0.97, 95% CI 0.88-1.07, p = 0.55), loss to follow-up

152 icant increase in risk of death at 6 months (RR, 1.05; 95% CI, 0.96-1.14).

153 rson-months vs 1.12 per 10000 person-months; RR, 0.99; 95% CI, 0.66-1.50).

154 rson-months vs 0.48 per 10000 person-months; RR, 2.15; 95% CI, 1.06-4.36), but not of other antidepre

155 5% CI, 0.70-1.03), cardiovascular mortality (RR, 0.84; 95% CI, 0.59-1.18), myocardial infarction (RR,

156 0 to 0.84), 33% in cardiovascular mortality (RR: 0.67; 95% CI: 0.45 to 0.98), and 37% in heart failur

157 ithout PPM have similar all-cause mortality (RR, 0.85; 95% CI, 0.70-1.03), cardiovascular mortality (

158 Nationally, among the 2,340 and 2,311 new RR-TB patients in the 2011 and 2013 cohorts, 55% (95% CI

159 ated treatment at 6 mo between the 1,368 new RR-TB patients diagnosed by Xpert (62%, 95% CI 59%-65%)

160 o for each 1 SD lower SD of normal-to-normal RR intervals was 1.14 (95% confidence interval: 1.08 to

161 -hospital behavioral interventions were not (RR: 1.05; 95% CI, 0.78-1.43).

162 fruits (RR: 0.94; 95% CI: 0.92, 0.97), nuts (RR: 0.76; 95% CI: 0.69, 0.84), and fish (RR: 0.93; 95% C

163 tinopathy (RR 13.1), retinal vein occlusion (RR 12.9), macular hole (RR 7.7), and epiretinal membrane

164 detection with Xpert, a larger proportion of RR-TB patients overall have received treatment, with red

165 his study, we set to investigate the role of RR in PEL pathogenesis and to evaluate its potential as

166 An optimal RR TB regimen reduced RR TB incidence by an estimated 32

167 nts (RR, 1.07; 95% CI, 1.01-1.12; P = .01 or RR, 1.49; 95% CI, 1.22-1.82; P < .001, depending on the

168 ding multiple melanoma, and in reverse order RR for melanoma in families of multiple discordant cance

169 104 (10.4%) of 998 patients undergoing ORR (RR, 1.31; 95% CI, 1.05-1.64; P = .02; I2 = 0%) in 5 stud

170 ssociated with type 2 diabetes risk overall (RR per interquintile range 0.96, 95% CI 0.88-1.05; p=0.3

171 not having SMR (21 studies, 21081 patients; RR, 1.96; 95% CI, 1.67-2.31; P < .001, I2 = 74%).

172 se mortality rate (9 studies, 3649 patients; RR, 1.97; 95% CI, 1.71-2.27; P < .001, I2 = 0%).

173 was most significant in contralateral PCME (RR 19.5), diabetic retinopathy (RR 13.1), retinal vein o

174 o the best intervention to reduce pneumonia (RR = 0.28; 95% CI, 0.09-0.90), sepsis (RR = 0.09; 95% CI

175 antly more likely to deliver preterm (pooled RR 1.20, 95% CI 1.01-1.44) or very preterm (1.53, 1.22-1

176 oping of cognitive disorders, and the pooled RR (95% CI) was 0.79 (0.70, 0.90).

177 with fair or poor quality bowel preparation (RR vs excellent quality, 2.16; 95% CI, 1.66-2.83).

178 2% were newly diagnosed with RR-TB (no prior RR-TB diagnoses).

179 ar risk factors, higher levels of NT-proBNP (RR, 3.19; 95% CI, 2.62-3.90) and hs-cTnT (RR, 4.86; 95%

180 30% higher risk for clinical AL progression (RR = 1.30; 95% CI: 1.07 to 1.58) than non-drinkers.

181 low-up, as well as a diagnosis of psychosis (RR=2.3 and 2.4, respectively; both p<0.001), independent

182 site-directed mutagenesis, resonance Raman (RR), hydrogen-deuterium exchange MS (HDX-MS) methods, an

183 ischemia, and estimate the respiration rate (RR) and tidal volume (TV) from analysis of electrocardio

184 (n = 23) was defined as a respiratory rate (RR) < 55 and room air oxygen saturation (SaO2) >/= 97%,

185 nsulin glargine U100 group for a rate ratio (RR) of 0.89 (95% CI, 0.85-0.94; P < .001 for noninferior

186 stantial reduction in mortality [risk ratio (RR) 0.63, 95% confidence interval (CI) 0.49-0.79, P = 0.

187 We estimated the risk ratio (RR) for preterm birth with maternal GBS colonization to

188 The unadjusted risk ratio (RR) of being retained at 12 months with HIV-1 RNA <50 co

189 etwork meta-analysis to estimate risk ratio (RR) with 95% confidence interval (CI).

190 ids (9.3% and 3.1% respectively, risk ratio (RR)=3.9, 95% confidence interval (CI) 2.4 to 6.1, p<0.00

191 nary embolism (2.6% versus 1.3%; rate ratio [RR] 2.0; 95% CI 1.2-3.2; P = 0.005) and required greater

192 14 from 8.2 to 27.2 per 100 000 (rate ratio [RR] 3.34, 95% CI 3.23-3.45; p<0.0001); further increases

193 Boys (rate ratio [RR] = 1.47) and children with higher unhealthy diet scor

194 the most effective intervention (rate ratio [RR], 0.05 [95% confidence interval {CI}, .01-.38]).

195 0%) was associated with a 15.4% (rate ratio [RR]: 0.846; 95% CI: 0.796-0.899) reduction in ACSC morta

196 nfavorable periodontal outcomes (rate ratio [RR]: 1.45 for AL and BOP in different teeth; RR: 1.84 fo

197 teplase group 48% vs saline 45%; risk ratio [RR] 1.06 [95% CI 0.88-1.28; p=0.554]).

198 repair vs 34/435 [8%] with mesh, risk ratio [RR] 1.08, 95% CI 0.68 to 1.72; p=0.73; graft trial: 23/3

199 sed risk of all-cause mortality (risk ratio [RR] 1.14 [95% CI 1.05-1.24] for streptokinase plus paren

200 with increased plaque formation (risk ratio [RR] 1.24, 95% confidence interval [CI] 1.07-1.43).

201 rd of care arm, both at 1 month (risk ratio [RR] 1.33, 95% CI 1.17-1.51, p < 0.001) and at 4 months (

202 risk for dual-strain infection (risk ratio [RR] = 9.20, 95% CI = 2.05-41.32), as did people who were

203 educed by 55% compared with AMT (risk ratio [RR], 0.45, 95% CI, 0.21-0.99).

204 ng individuals administered ECT (risk ratio [RR], 0.54; 95% CI, 0.28-0.81).

205 0.01; 95% CI, -0.07 to 0.10 and risk ratio [RR], 0.96; 95% CI, 0.77 to 1.21).

206 iagnosed with melanoma (adjusted risk ratio [RR], 2.4; 95% CI, 1.7-3.4; P < .001) and to have a thinn

207 rything that was possible (crude risk ratio [RR], 3.5; 95% CI, 2.3 to 5.1) and for having stopped tre

208 SMR (17 studies, 26359 patients; risk ratio [RR],1.79; 95% CI, 1.47-2.18; P < .001, I2 = 85%); when S

209 High acrylamide relative recovery (RR=82.7-105.2%) of acrylamide was obtained for spiked (5

210 ning RR TB treatment from 20 to 6 mo reduced RR TB mortality by 8% (95% UR: 4%-13%), while reducing n

211 An optimal RR TB regimen reduced RR TB incidence by an estimated 32% (95% UR: 18%-46%) an

212 tly found that the ribonucleotide reductase (RR) subunit M2 is potentially regulated by the key oncog

213 sk of bleeding compared with other regimens (RR 0.79 [95% CI 0.63-1.00]).

214 changes in a short loop (loop 2) to regulate RR specificity among its nucleoside diphosphate substrat

215 ld insight into loop 2's roles in regulating RR specificity, allostery, and oligomerization.

216 y genes to biosynthesize resistance related (RR) metabolites to contain the pathogen to spikelet infe

217 lipoprotein profile of relapsing-remitting (RR) MS patients, progressive MS patients and healthy con

218 8%) vs 25685 of 43310 (59.3%), respectively (RR = 0.97; 95% CI, 0.96-0.99; P < .001).

219 ME among patients with diabetic retinopathy (RR 1.06, 95% 0.81-1.38).

220 ateral PCME (RR 19.5), diabetic retinopathy (RR 13.1), retinal vein occlusion (RR 12.9), macular hole

221 (3) death, MI, or repeat revascularization (RR); and (4) hospitalized bleeding were compared using C

222 creases were shown by miconazole-rifampicin (RR, 0.14 [95% CI, .05-.36]), 5-fluorouracil (RR, 0.34 [9

223 >1 glass/day had significantly higher risk (RR = 1.50; 95% CI: 1.08 to 1.99).

224 by 32% on high snowfall days (relative risk (RR) = 0.68, 95% confidence interval (CI): 0.54, 0.85) bu

225 hair, multivariable-adjusted relative risk (RR) = 0.99, 95% confidence interval (CI): 0.90, 1.09), s

226 self-reported general health (relative risk (RR) = 1.28; 95% confidence interval (CI): 1.06, 1.53), c

227 ting equations calculated the relative risk (RR) and 95% confidence interval for early deliveries ass

228 summarized as Mantel-Haenszel relative risk (RR) and 95% confidence intervals (CIs) for dichotomous v

229 cer Database, we assessed the relative risk (RR) for any cancer in families with increasing numbers o

230 CRC (Ptrend < .0001), with a relative risk (RR) of 1.31 (95% CI, 1.15-1.48, comparing the highest to

231 Relative risk (RR) of psoriasis was estimated by Cox regression.

232 PCME relative risk (RR) was most significant in contralateral PCME (RR 19.5)

233 termining the incidence rate, relative risk (RR), and survival probability with respect to NLP outcom

234 ld of 16 degrees C revealed a relative risk (RR)=1.14 (95% CI: 1.02, 1.27; p=0.024) for a lag of 2 wk

235 ses per 10 000 exposure days; relative risk [RR] 0.70, 95% CI 0.50-0.98; p=0.036).

236 r in adults aged 19-64 years (relative risk [RR] 0.85, 95% CrI 0.75-0.95) and 65 years and older (0.8

237 osite outcome of death or CP (relative risk [RR] 0.94, 95% confidence interval (CI) 0.85 to 1.05, 6,1

238 the control group, had died (relative risk [RR] of mortality 0.67, 95% CI 0.42-1.08; p=0.11).

239 cluded African American race (relative risk [RR] to white, 1.41; 95% confidence interval [CI], 1.14-1

240 t dropout due to progression (relative risk [RR], 0.32; 95% confidence interval [CI], 0.06-1.85; I(2)

241 on was lowest among children (relative risk [RR], 0.44 [95% confidence interval {CI}, .23-.85]; P = .

242 sting for common confounders (relative risk [RR], 0.46; 95% CI, 0.11-1.93).

243 treatment groups (59 deaths; relative risk [RR], 1.02; 95% CI, 0.72-1.45; P = .92).

244 likelihood of PCI at outlier (relative risk [RR], 1.13; 95% confidence interval [CI], 1.12-1.15) and

245 he switch group in remission (relative risk [RR], 1.30 [95% CI, 1.05-1.60]; P = .02), but other remis

246 ssion, alcoholism, or autism (relative risk [RR], 1.50; 95% CI, 1.08-2.17; P = .02).

247 10000 person-months; adjusted relative risk [RR], 1.88; 95% CI, 1.34-2.64) and tricyclic or other cyc

248 duction in recurrent syncope (relative risk [RR]: 0.30; 95% confidence interval [CI]: 0.15-0.60).

249 is revealed that varenicline (relative risk [RR]: 2.64; 95% confidence interval [CI], 1.34-5.21) and

250 (RR, 1.02; 95% CI, 1.01-1.02), but not RSV (RR, 0.99; 95% CI, .98-1.01), had a significant associati

251 children with higher unhealthy diet scores (RR = 1.08) complied more, but overweight/obese children

252 onia (RR = 0.28; 95% CI, 0.09-0.90), sepsis (RR = 0.09; 95% CI, 0.01-0.94), hospital stay (mean = 9.6

253 2), as did people who were HIV seropositive (RR = 4.06, 95% CI = 1.42-11.56).

254 hic study was performed at the clinician set RR interval and at heart rates from 70 to 110 beats/min,

255 tality by 3% (95% UR: 1%-6%), and shortening RR TB treatment from 20 to 6 mo reduced RR TB mortality

256 memory impairment was no longer significant (RR [95% CI]: 1.18 [0.95-1.47], p = 0.13).

257 screen activities (RR = 0.98) and sleeping (RR = 0.96) had the lowest compliance.

258 crease risk for SP included tobacco smoking (RR, 2.47; 95% CI, 2.12-2.87), alcohol intake (RR, 1.33;

259 n in reducing surgical site infection (SSI) (RR = 0.28; 95% CI, 0.12-0.64) in adult surgical patients

260 itiating a different versus the same statin (RR, 1.10; 95% CI, 1.06-1.14) were associated with high p

261 n (RR, 0.47; 95% CI, 0.20-1.11), and stroke (RR, 1.26; 95% CI, 0.70-2.26) at 30 days.

262 ociated with a 15% increased risk of stroke (RR 1.15; 95% CI, 1.03 to 1.28).

263 ated with GBS bacteriuria in cohort studies (RR, 1.98 [95% CI, 1.45-2.69]; P < .001).

264 82]), and chlorhexidine-silver sulfadiazine (RR, 0.60 [95% CI, .50-.72]) impregnations compared with

265 n of both medication administration systems (RR=4.3, 95%CI 2.7 to 6.8, p<0.001).

266 al obesity on AL and BOP in different teeth (RR: 1.44).

267 eased risk of AL and BOP in different teeth (RR: 1.47), AL and BOP in the same tooth (RR: 2.77), and

268 RR]: 1.45 for AL and BOP in different teeth; RR: 1.84 for AL and BOP in the same tooth).

269 to follow-up at 12 months after HIV testing (RR 0.56, 95% CI 0.40-0.79, p = 0.002), and death (N = 78

270 th (N = 78) within 12 months of HIV testing (RR 0.80, 95% CI 0.46-1.35, p = 0.41).

271 Taken together, we propose that RR and its signaling pathway may serve as novel actionab

272 The RR of nongrowing season Rs and Rh decreased in years wit

273 rates, Kaplan-Meier survival curves, and the RR of NLP outcomes among eyes with aniridia were determi

274 SUVR using the SWM as the RR showed no significant differences at either follow-up

275 gnificant SUVR changes using the pons as the RR were detected only at 2 y (P = 0.46 [1 y], P = 0.001

276 e RNA profiling using RNA-Seq to compare the RR group and the complete remission (CR) group (a total

277 th adjustment for potential confounders, the RR of ID after antidepressant exposure was estimated at

278 l of foods was calculated by multiplying the RR by optimal intake values (serving category with the s

279 In RCTs, the RR for venous thromboembolism was 0.85 (0.73-0.99; p=0.0

280 We observed that the RR and TV estimation algorithms detected apnea within 7.

281 We report that the RR inhibitor 3-AP actively induces PEL cell cycle arrest

282 Telephone therapy (RR: 1.47; 95% CI: 1.15-1.88) and individual counseling (

283 th (RR: 1.47), AL and BOP in the same tooth (RR: 2.77), and percentage of BOP (RR: 1.49).

284 lphate treatment compared with no treatment (RR 0.86, 95% CI 0.75 to 0.99, 4,448 babies, 4 trials), w

285 .3 to 5.1) and for having stopped treatment (RR, 3.4; 95% CI, 2.1 to 6.0), self-destructiveness (eg,

286 burden of rifampicin-resistant tuberculosis (RR-TB), with 18,734 patients diagnosed in 2014.

287 ) detects rifampicin-resistant tuberculosis (RR-tuberculosis), enabling physicians to rapidly initiat

288 o the standard ART group, and the unadjusted RR for being retained with HIV-1 RNA <1,000 copies was 1

289 The unadjusted RR of ID was increased in offspring born to mothers trea

290 and highest during the first 30 days of use (RR, 1.68; 95% CI, 0.90-3.12).

291 diabetes increased with the duration of use (RR, 2.66; 95% CI, 1.45-4.88 for >210 days and RR, 2.56;

292 with more than 150 days of SSRI or SNRI use (RR, 2.39; 95% CI, 1.04-5.52 for >15.0 vs </=15.0 mg/d) b

293 (RR: 0.92; 95% CI: 0.89, 0.95), vegetables (RR: 0.96; 95% CI: 0.95, 0.98), fruits (RR: 0.94; 95% CI:

294 ent in patients with VHD versus without VHD (RR:1.01; 95% CI: 0.90 to 1.14 vs. RR: 0.88; 95% CI: 0.82

295 irearm injuries from interpersonal violence (RR, 2.23 [CI, 1.01 to 4.89]) but corresponded to a small

296 thout VHD (RR:1.01; 95% CI: 0.90 to 1.14 vs. RR: 0.88; 95% CI: 0.82 to 0.94, respectively; interactio

297 ed for treatment of patients of any age with RR-DTC.

298 respectively; 92% were newly diagnosed with RR-TB (no prior RR-TB diagnoses).

299 Many South Africans diagnosed with RR-tuberculosis by Xpert initiate a suboptimal regimen,

300 4), and highest in persons aged >/=65 years (RR, 1.72 [95% CI, 1.25-2.35]; P < .001).